The program, which allows qualifying healthcare providers to purchase outpatient drugs at discounted prices, is a significant source of funding for many healthcare organizations in the state.
Here are four key takeaways from the report:
- The state’s largest 340B hospitals accounted for about 80% of the total revenue, amounting to roughly $500 million. These hospitals made up just 13% of the reporting entities but filled the majority of prescriptions under the program.
- Federally qualified health centers and similar safety-net clinics generated the least revenue from the program.
- The report showed that approximately $87 million, or 14% of total net 340B revenue, was generated through payments from Minnesota’s Medicaid programs.
- Covered entities paid more than $120 million to third-party administrators and contract pharmacies, representing 16% of the gross 340B revenue generated.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.